Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CARBINOXAMINE MALEATE

CARBINOXAMINE MALEATE

Standard Dose
4MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CARBINOXAMINE MALEATE is listed in Drugs@FDA under application 090418 (ANDA).

Marketing status: Discontinued Active ingredient CARBINOXAMINE MALEATE Form and strength SOLUTION;ORAL - 4MG/5ML Sponsor CYPRESS PHARM Submission history Latest submission status date: 2010-05-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview CARBINOXAMINE MALEATE is listed in Drugs@FDA under application 090418 (ANDA). Marketing status: Discontinued Active ingredient CARBINOXAMINE MALEATE Form and strength SOLUTION;ORAL - 4MG/5ML Sponsor CYPRESS PHARM Submission history Latest submission status date: 2010-05-04 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.